AVISE® HCQ is an advanced drug monitoring test that provides accurate measurement of HCQ levels in whole blood to help physicians assess their patients' exposure to HCQ therapy.

Now compatible with



Evaluate a patient's risk for disease flares.  Patients are 4 times more likely to develop flares if HCQ levels are <1000 ng/mL2.

To learn more about the clinical utility of AVISE® HCQ from your peers or read current scientific publications, please visit our Education & Resources library.

Request more information on AVISE® testing

Pin It on Pinterest

Share This